Picus 700 WS

Primær information

  • Handelsnavn:
  • Picus 700 WS Vanddispergerbart pulver til bejdsning i opslemning
  • Lægemiddelform:
  • Vanddispergerbart pulver til bejdsning i opslemning
  • Sammensætning:
  • 700 g/kg imidacloprid
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • Picus 700 WS Vanddispergerbart pulver til bejdsning i opslemning
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Autorisationsnummer:
  • 11-37
  • Sidste ændring:
  • 08-02-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.

21-3-2018

Porcilis PCV ID (Intervet International B.V.)

Porcilis PCV ID (Intervet International B.V.)

Porcilis PCV ID (Active substance: Porcine circovirus type 2 ORF2 subunit antigen) - Centralised - 2-Monthly update - Commission Decision (2018) 1771 of Wed, 21 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/3942/WS/1277

Europe -DG Health and Food Safety

22-12-2017

Ebymect (AstraZeneca AB)

Ebymect (AstraZeneca AB)

Ebymect (Active substance: dapagliflozin / metformin) - Centralised - 2-Monthly update - Commission Decision (2017)9089 of Fri, 22 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4162/WS/1271G

Europe -DG Health and Food Safety

22-12-2017

Xigduo (AstraZeneca AB)

Xigduo (AstraZeneca AB)

Xigduo (Active substance: dapagliflozin/metformin) - Centralised - 2-Monthly update - Commission Decision (2017)9087 of Fri, 22 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2672/WS/1271/G

Europe -DG Health and Food Safety

19-12-2017

Eviplera (Gilead Sciences International Limited)

Eviplera (Gilead Sciences International Limited)

Eviplera (Active substance: emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as fumarate)) - Centralised - 2-Monthly update - Commission Decision (2017)8907 of Tue, 19 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2312/WS/1251

Europe -DG Health and Food Safety

19-12-2017

Efficib (Merck Sharp and Dohme Limited)

Efficib (Merck Sharp and Dohme Limited)

Efficib (Active substance: sitagliptin / metformin hydrochloride) - Centralised - 2-Monthly update - Commission Decision (2017) 8911 of Tue, 19 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/896/WS/1212/G

Europe -DG Health and Food Safety

19-12-2017

Velmetia (Merck Sharp and Dohme Limited)

Velmetia (Merck Sharp and Dohme Limited)

Velmetia (Active substance: sitagliptin / metformin hydrochloride) - Centralised - 2-Monthly update - Commission Decision (2017) 8913 of Tue, 19 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/862/WS/1212/G

Europe -DG Health and Food Safety

19-12-2017

Janumet (Merck Sharp and Dohme Limited)

Janumet (Merck Sharp and Dohme Limited)

Janumet (Active substance: sitagliptin / metformin hydrochloride) - Centralised - 2-Monthly update - Commission Decision (2017) 8912 of Tue, 19 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/861/WS/1212/G

Europe -DG Health and Food Safety

14-12-2017

ANTI-AGING FOUNDATION SPF 15 SHADE 700 (Octinoxate) Emulsion [La Prairie, Inc.]

ANTI-AGING FOUNDATION SPF 15 SHADE 700 (Octinoxate) Emulsion [La Prairie, Inc.]

Updated Date: Dec 14, 2017 EST

US - DailyMed

13-12-2017

Reyataz (Bristol-Myers Squibb Pharma EEIG)

Reyataz (Bristol-Myers Squibb Pharma EEIG)

Reyataz (Active substance: atazanavir sulphate) - Centralised - 2-Monthly update - Commission Decision (2017)8697 of Wed, 13 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/494/WS/1193

Europe -DG Health and Food Safety

13-12-2017

Odefsey (Gilead Sciences International Limited)

Odefsey (Gilead Sciences International Limited)

Odefsey (Active substance: emtricitabine / rilpivirine / tenofovir alafenamide) - Centralised - 2-Monthly update - Commission Decision (2017)8696 of Wed, 13 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4156/WS/1251

Europe -DG Health and Food Safety

13-12-2017

EVOTAZ (Bristol-Myers Squibb Pharma EEIG)

EVOTAZ (Bristol-Myers Squibb Pharma EEIG)

EVOTAZ (Active substance: atazanavir / cobicistat) - Centralised - 2-Monthly update - Commission Decision (2017) 8701 of Wed, 13 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/3904/WS/1193

Europe -DG Health and Food Safety

25-10-2017

Liprolog (Eli Lilly Nederland B.V.)

Liprolog (Eli Lilly Nederland B.V.)

Liprolog (Active substance: Insulin lispro) - Centralised - 2-Monthly update - Commission Decision (2017)7238 of Wed, 25 Oct 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/393/WS/1158/G

Europe -DG Health and Food Safety

23-10-2017

Humalog (Eli Lilly Nederland B.V.)

Humalog (Eli Lilly Nederland B.V.)

Humalog (Active substance: Insulin lispro) - Centralised - 2-Monthly update - Commission Decision (2017)7168 of Mon, 23 Oct 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/88/WS/1158/G

Europe -DG Health and Food Safety

13-7-2017

IMIDACLOPRID Powder [Wisdom Pharmaceutical Co.,Ltd]

IMIDACLOPRID Powder [Wisdom Pharmaceutical Co.,Ltd]

Updated Date: Jul 13, 2017 EST

US - DailyMed

28-6-2017

Onglyza (AstraZeneca AB)

Onglyza (AstraZeneca AB)

Onglyza (Active substance: saxagliptin) - Centralised - 2-Monthly update - Commission Decision (2017)4525 of Wed, 28 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/1039/WS/1078

Europe -DG Health and Food Safety

28-6-2017

Komboglyze (AstraZeneca AB)

Komboglyze (AstraZeneca AB)

Komboglyze (Active substance: saxagliptin / metformin) - Centralised - 2-Monthly update - Commission Decision (2017)4518 of Wed, 28 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2059/WS/1078

Europe -DG Health and Food Safety

8-6-2017

Advocate (Bayer Animal Health GmbH)

Advocate (Bayer Animal Health GmbH)

Advocate (Active substance: imidacloprid and moxidectin) - Centralised - Yearly update - Commission Decision (2017)4001 of Thu, 08 Jun 2017

Europe -DG Health and Food Safety

7-6-2017

Norvir (AbbVie Ltd)

Norvir (AbbVie Ltd)

Norvir (Active substance: Ritonavir) - Centralised - 2-Monthly update - Commission Decision (2017)3953 of Wed, 07 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/127/WS/1077/143/G

Europe -DG Health and Food Safety